- In July 2024, Shanghai United Imaging Healthcare Co., Ltd. announced the installation of its first PET/CT scanner in Mexico at the Instituto Nacional de Pediatría. This marks a significant milestone in expanding access to advanced imaging technology in the region. The installation of this cutting-edge scanner will enhance diagnostic capabilities, particularly in pediatric care, offering high-resolution imaging for more accurate and efficient disease detection
- In June 2024, GE Healthcare expanded its technology portfolio with the launch of several groundbreaking innovations. The MINItrace Magni, a compact cyclotron, enables reliable in-house production of commercial PET tracers and radiometals. Along with the Omni Legend 21 cm PET/CT system, designed to meet the growing demands of healthcare systems, and Clarify DL, a new deep learning reconstruction technology, GE Healthcare is enhancing imaging accuracy, efficiency, and accessibility across a range of medical specialties. These advancements are set to improve diagnostic capabilities and streamline healthcare operations globally
- In February 2024, GE Healthcare partnered with MedQuest Associates (MedQuest) for a three-year collaboration focused on enhancing patient care. By combining GE Healthcare's cutting-edge technologies with MedQuest's extensive infrastructure, the partnership aims to optimize multi-site outpatient imaging networks for improved operational success. This alliance demonstrates a shared commitment to providing advanced healthcare solutions while prioritizing both patient satisfaction and access to high-quality care across multiple locations
- In October 2022, United Imaging Healthcare unveiled its total-body PET/CT system, the uEXPLORER, featuring a 194 cm axial PET field of view (FOV), enabling full-body scans in a single bed position. This ultra-high-resolution digital system offers total-body dynamic scanning with an ultra-low patient dose while delivering exceptional image clarity. The uEXPLORER is set to revolutionize whole-body PET/CT imaging, enhancing diagnostic precision and patient safety
- In October 2022, GE Healthcare launched the Omni Legend positron emission tomography/computed tomography (PET/CT) platform at the 35th Annual Congress of the European Association of Nuclear Medicine (EANM) in Barcelona, Spain. The Omni Legend platform is designed to enhance imaging accuracy and patient care by providing high-resolution imaging and improved scan efficiency. This cutting-edge technology aims to set new standards in PET/CT imaging, offering advanced capabilities for better diagnostics in oncology, cardiology, and neurology
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (SPECT Systems, Hybrid PET Systems, and Planar Scintigraphy), Application (Oncology, Cardiology, Neurology, and Others), End-User (Hospitals, Imaging Centers, Academic and Research Centers, and Others) – Industry Trends and Forecast to 2032
.
The Global Advanced Molecular Nuclear Imaging Market size was valued at USD 5.40 USD Billion in 2024.
The Global Advanced Molecular Nuclear Imaging Market is projected to grow at a CAGR of 5.61% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
